Fresenius Medical Care AG & Co. KGaA Investor Relations Investor News Else-Kr ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: ir@fmc-ag.com North America: Te

Fresenius Medical Care Successfully Placed

Senior Notes in the Amount of US$ 500 million

Bad Homburg, Germany June 26, 2007 Fresenius Medical Care AG

& Co. KGaA ( the Company ), the world s largest provider of

Dialysis Products and Services, today announced the pricing of Senior Notes due

2017 in the amount of US$ 500 million. The coupon will be

6 7/8%. Proceeds will be used to reduce indebtedness

under the Company s senior secured bank credit facility and other

The Senior Notes will be issued by FMC Finance III S.A., a wholly-owned

subsidiary of the Company, and will be guaranteed on a senior basis jointly and

severally by the Company, Fresenius Medical Care Holdings, Inc. and Fresenius

Medical Care Deutschland GmbH.

Lawrence A. Rosen, Chief Financial Officer of Fresenius Medical Care, commented:

We are pleased to have successfully completed the company s first

senior unsecured bond offering. Investors have clearly recognized our

sustainable financial strength and are confident in the future of the industry

and Fresenius Medical Care.

The notes were not registered under the Securities Act of 1933, but were offered

in the United States pursuant to an exemption of registration under Rule 144 A,

as well as outside the United States under Regulation S. The notes may not be

offered or sold in the United States without registration or an applicable

exemption from the registration requirements.

Fresenius Medical Care is the world s largest integrated provider of

products and services for individuals undergoing dialysis because of chronic

kidney failure, a condition that affects more than 1,500,000 individuals

worldwide. Through its network of 2,194 dialysis clinics in North America,

Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides

dialysis treatment to 169,216 patients around the globe. Fresenius Medical Care

is also the world s leading provider of dialysis products such as

hemodialysis machines, dialyzers and related disposable products. Fresenius

Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New

York Stock Exchange (FMS, FMS/P).

For more information about Fresenius Medical Care visit the Company s

website at www.fmc-ag.com.

This release contains forward-looking statements that are subject to various

risks and uncertainties. Actual results could differ materially from those

described in these forward-looking statements due to certain factors, including

changes in business, economic and competitive conditions, regulatory reforms,

foreign exchange rate fluctuations, uncertainties in litigation or investigative

proceedings, and the availability of financing. These and other risks and

uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA s

reports filed with the U.S. Securities and Exchange Commission. Fresenius

Medical Care AG & Co. KGaA does not undertake any responsibility to update

the forward-looking statements in this release.